FDA recall D-0265-2023

Akorn, Inc. · Class III · drug

Product

Atropine Sulfate Ophthalmic Solution, USP 1%, For Topical Application To The Eye, 2 mL bottle, Sterile, Rx only, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031. NDC: 17478-215-02

Reason for recall

Failed Stability Specifications: Out of specification test results for viscosity was identified at the 12M stability timepoint.

Distribution

Nationwide in the USA and Puerto Rico

Key facts

Status
Ongoing
Initiation date
2023-01-30
Report date
2023-02-15
Voluntary/Mandated
Voluntary: Firm initiated
Location
Gurnee, IL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0265-2023